CPT code 87541 covers a molecular diagnostic test that detects Legionella pneumophila using an amplified nucleic acid probe. This assay is used to identify a key bacterial cause of Legionnaires’ disease and is important for outbreak detection and infection control in facilities with complex water or HVAC systems. Nationally, timely and accurate identification of L. pneumophila influences public health responses and clinical management of suspected legionellosis.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The analysis addresses payer coverage patterns, where available, and situates the test within laboratory service lines and hospital infection-control workflows.

Readers will learn the clinical context of the assay, typical sites of service, and what to expect from payer coverage descriptions. The publication summarizes benchmarks and policy-relevant considerations for molecular infectious disease testing, highlights clinical utility for outbreak investigations, and notes where input data are incomplete. Data not available in the input are explicitly identified in the introduction and supporting tables.